Credit: Nestlé

Nestlé’s efforts to attract users of GLP-1 drugs in the US now include the launch of protein shots.

The company is rolling out Boost Pre-meal, a liquid shot the Swiss giant said will “support people using GLP-1 receptor agonists or other weight-loss medications”.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The shots, available as a “limited edition” are, Nestlé chief technology officer Stefan Palzer said, “designed to help manage hunger and the feeling of satisfaction when consumed before meals”.

According to a website for the Boost brand, the shots are available via Amazon and in CVS stores.

The Amazon listing shows the 125ml shots on sale in a pack of four.

Earlier this year, Nestlé announced plans to launch a range of meals in the US designed as a “companion” for those taking GLP-1 weight-loss medication.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The world’s largest food maker described the Vital Pursuit products as “high in protein, a good source of fibre, contain essential nutrients and … are portion-aligned to a weight loss medication user’s appetite”.

Nestlé started selling the range of pasta, pizza and sandwich melts during the fourth quarter.

Last week, US food manufacturer Conagra Brands set out plans to affix labels on some of its Healthy Choice products in the new year in a bid to catch the eye of users of GLP-1 drugs.

The “On Track” badge will be used on Healthy Choice SKUs that are “high in protein, low in calories and a good source of fibre”, the US manufacturer said, claiming the 26 products are “GLP-1 friendly”.

Conagra Brands said the move is a response to the increasing use of GLP-1 medication in the US. Without citing the source of the data, the Hunt’s ketchup maker said the drugs are used by nearly 15 million adults in the US to manage Type 2 diabetes and support weight loss.